CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Long-term debt (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $248M | +56.0% | 39.8% | 32.6% |
| Long-term debt (Q2 2026) | $248M |
|---|---|
| YoY | +56.0% |
| 5-year CAGR | 39.8% |
| 10-year CAGR | 32.6% |
Long-term debt
| Period | Long-term debt | YoY |
|---|---|---|
| 2025 | $246M | +164.3% |
| 2024 | $93M | +59.7% |
| 2023 | $58M | −8.5% |
| 2022 | $64M | +34.7% |
| 2021 | $47M | +2.5% |
| 2020 | $46M | +2.6% |
| 2019 | $45M | +13.2% |
| 2018 | $40M | +25.3% |
| 2017 | $32M | +16.1% |
| 2016 | $27M | +87.0% |
| 2015 | $15M | — |
| 2014 | $0 | — |